Maki Tanioka

7PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 03, 2026
Serum albumin is associated with immune-related hypothyroidism and treatment continuity in non-small cell lung cancer.

|Oct 12, 2025
Clinical significance on switching CDK4/6 inhibitors among 13,284 patients with metastatic breast cancer.

Takuya Nishina, Maki Tanioka, Kenji Takada

|Jul 29, 2025
Definitions of, Advances in, and Treatment Strategies for Breast Cancer Oligometastasis.

Tadahiko Shien, Shogo Nakamoto, Yuki Fujiwara

|Oct 16, 2024
Real-World Comparative Analysis of Trastuzumab Originator and Biosimilars: Safety, Efficacy, and Cost Effectiveness.

Tomoka Mamori, Maki Tanioka, Kenji Takada

|Oct 17, 2022
High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer.

Shu Yazaki, Yuki Kojima, Hiroshi Yoshida

|Sep 01, 2021
Clinical management and outcomes associated with etoposide, doxorubicin, and cisplatin plus mitotane treatment in metastatic adrenocortical carcinoma: a single institute experience.

Masaki Uchihara, Maki Tanioka, Yuki Kojima

Pageof 2

Frequent Collaborators

1 joint publications

Shu Yazaki

1 joint publications

Yuki Kojima

1 joint publications

Hiroshi Yoshida

1 joint publications

Shigemasa Takamizawa